Health Care & Hospital Law,
Civil Litigation
May 20, 2021
State’s expert admits bias against opioids
An attorney for opioid manufacturers on Wednesday played a recording of the state’s star witness acknowledging she was biased in a $50 billion false advertising trial in which several local governments accused Purdue Pharma and other drugmakers of downplaying in promotion materials the risks of prescription drug addiction.




An attorney for opioid manufacturers on Wednesday played a recording of the state's star witness acknowledging she was biased in a $50 billion false advertising trial in which several local governments accused Purdue Pharma and other drugmakers of downplaying in promotion materials the risks of prescription drug addiction.
Testifying via Zoom Tuesday, Dr. Anna Lembke of Stanford School of Medicine, a key witness for the state, said...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In